These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19652041)

  • 1. Does measuring natriuretic peptides have a role in patients with chronic kidney disease?
    Hajjar V; Schreiber MJ
    Cleve Clin J Med; 2009 Aug; 76(8):476-8. PubMed ID: 19652041
    [No Abstract]   [Full Text] [Related]  

  • 2. Are natriuretic peptides a reliable marker for mortality in ESRD patients?
    Locatelli F; Viganò S
    Nephrol Dial Transplant; 2010 Feb; 25(2):347-9. PubMed ID: 19934079
    [No Abstract]   [Full Text] [Related]  

  • 3. Can we IMPROVE-CHF management by measuring natriuretic peptides?
    Greenberg B
    Circulation; 2007 Jun; 115(24):3045-7. PubMed ID: 17576881
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biomarkers in heart failure: are they clinically useful?].
    Kempf T; Wollert KC
    Dtsch Med Wochenschr; 2009 Apr; 134(15):740-6. PubMed ID: 19340752
    [No Abstract]   [Full Text] [Related]  

  • 5. Natriuretic peptides in the diagnosis and management of acute heart failure.
    Mohammed AA; Januzzi JL
    Heart Fail Clin; 2009 Oct; 5(4):489-500. PubMed ID: 19631174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natriuretic peptides in heart failure: empathizing with the sobbing heart..
    Narula J; Young JB
    Heart Fail Clin; 2006 Jul; 2(3):xi-xiii. PubMed ID: 17386893
    [No Abstract]   [Full Text] [Related]  

  • 7. Natriuretic peptides as a prognostic marker and therapeutic target in heart failure.
    Wright GA; Struthers AD
    Heart; 2006 Feb; 92(2):149-51. PubMed ID: 16216866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tailored drug therapy in heart failure--a future vision. Biological markers can support individually directed treatment].
    Dahlström U
    Lakartidningen; 2009 Oct 14-20; 106(42):2674-5. PubMed ID: 19967945
    [No Abstract]   [Full Text] [Related]  

  • 9. [Role of biomarkers for risk stratification in the tailored follow-up of heart failure patients].
    Aspromonte N; Di Tano G; Latini R; Masson S; Valle R; Emdin M
    G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 2):17S-23S. PubMed ID: 20873464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Will the therapy of chronic heart failure be guided by plasma levels of natriuretic peptides?].
    Hradec J; Krupicka J; Janota T
    Cas Lek Cesk; 2009; 148(8):383-8. PubMed ID: 19899725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sepsis and those who are "weak of heart".
    van Kimmenade RR; Bajwa E; Januzzi JL
    Crit Care Med; 2008 Nov; 36(11):3108-9. PubMed ID: 18941317
    [No Abstract]   [Full Text] [Related]  

  • 12. Biomarkers in heart failure.
    Braunwald E
    N Engl J Med; 2008 May; 358(20):2148-59. PubMed ID: 18480207
    [No Abstract]   [Full Text] [Related]  

  • 13. Natriuretic peptides and heart failure in the patient with chronic kidney disease: a review of current evidence.
    Dhar S; Pressman GS; Subramanian S; Kaul S; Gollamudi S; Bloom EJ; Figueredo VM
    Postgrad Med J; 2009 Jun; 85(1004):299-302. PubMed ID: 19528304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role and assessment of ventricular peptides in heart failure.
    Winter WE; Elin RJ
    Clin Lab Med; 2004 Mar; 24(1):235-74. PubMed ID: 15157565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natriuretic peptide-guided management of patients with heart failure: a decade of progress but still a controversy.
    Baibars M; Ibrahim A; Fang JC; Sipahi I
    Future Cardiol; 2010 Nov; 6(6):743-7. PubMed ID: 21142628
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of natriuretic peptides as biomarkers for guiding the management of chronic heart failure.
    Motiwala SR; Januzzi JL
    Clin Pharmacol Ther; 2013 Jan; 93(1):57-67. PubMed ID: 23187878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natriuretic peptides and the heart: current and future implications for clinical biochemistry.
    Penney MD
    Ann Clin Biochem; 2005 Nov; 42(Pt 6):432-40. PubMed ID: 16259793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood biomarker measurement as disease target: the case for generic treatment of high natriuretic peptide levels without a diagnosis of heart failure.
    Clark AL
    J R Coll Physicians Edinb; 2013; 43(2):99-100. PubMed ID: 23734347
    [No Abstract]   [Full Text] [Related]  

  • 19. Reducing variation: heart: Modelling helps to prove blood test value.
    Health Serv J; 2011 Sep; Suppl():18. PubMed ID: 22053508
    [No Abstract]   [Full Text] [Related]  

  • 20. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
    Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
    Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.